Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
  Home Print this page Email this page Small font sizeDefault font sizeIncrease font size Users Online: 10  

 
   Table of Contents      
CASE REPORT
Year : 2016  |  Volume : 15  |  Issue : 3  |  Page : 212-214

Radiation-induced leiomyosarcoma of the oral cavity: A rare occurrence detected on 18F-FDG PET/CT


1 Department of Pathology, National Institute of Pathology, Indian Council of Medical Research, New Delhi, India
2 Department of Radiotherapy, Safdarjung Hospital, New Delhi, India

Date of Web Publication31-Aug-2016

Correspondence Address:
Varsha Dalal
National Institute of Pathology, Indian Council of Medical Research, Safdarjung Hospital Campus, New Delhi - 110 029
India
Login to access the Email id


DOI: 10.4103/1450-1147.172306

PMID: 27651746

Rights and Permissions
   Abstract 

Radiation-induced sarcomas (RIS) or postirradiation sarcomas have been reported as a rare long-term complication of radiation therapy (RT). The survival benefit offered by radiotherapy has been masked by an increase in the incidence of these sarcomas, thus making radiotherapy a double-edged sword. RIS generally develop with a mean latency period of 10-15 years and encompass different histological types. We report a case of oral leiomyosarcoma with a rather short latency period of 4 years after the radiotherapy of the prior oral squamous cell carcinoma (OSCC) detected on fluorine-18 (18F)-fluoro-2-deoxy-D-glucose (FDG) positron emission tomography/computed tomography (PET/CT). The rarity of occurrence of leiomyosarcoma in the oral cavity is also highlighted.

Keywords: Leiomyosarcoma, oral cavity, radiation, squamous cell carcinoma


How to cite this article:
Siraj F, Dalal V, Kaur M, Suri K. Radiation-induced leiomyosarcoma of the oral cavity: A rare occurrence detected on 18F-FDG PET/CT. World J Nucl Med 2016;15:212-4

How to cite this URL:
Siraj F, Dalal V, Kaur M, Suri K. Radiation-induced leiomyosarcoma of the oral cavity: A rare occurrence detected on 18F-FDG PET/CT. World J Nucl Med [serial online] 2016 [cited 2020 Nov 24];15:212-4. Available from: http://www.wjnm.org/text.asp?2016/15/3/212/172306


   Introduction Top


Radiation-induced sarcomas (RIS) of the head and neck region, although a well-known complication of treatment, remain a rare diagnosis. They usually arise within the radiation field after radiation doses of 45-60 Gray (Gy), with a mean latency period of 10-15 years. Prognosis is poor with a survival rate of 10-30%. [1],[2]

RIS can be of variable histological subtypes, the most common being osteosarcoma and malignant fibrous histiocytoma/undifferentiated pleomorphic sarcoma-not otherwise specified (MFH/UPS-NOS). Leiomyosarcomas induced by radiotherapy are very rare, especially in the head and neck region. [1],[3] We report a case of leiomyosarcoma arising after radiation therapy (RT) for oral squamous cell carcinoma (OSCC).


   Case Report Top


A 70-year-old male presented with a growth in the right oral cavity for the past 6 months [Figure 1]a. Fluorine-18 (18F)-fluoro-2-deoxy-D-glucose (FDG) positron emission tomography/computed tomography (PET/CT) scan revealed a hypermetabolic well-defined homogenously enhancing soft tissue mass lesion in the oral cavity with a probable origin from anterior gingivobuccal mucosa with erosion of anterior cortex of mandible [Figure 1]b. Histopathologic examination of biopsy from the swelling revealed an ulcerated mucosa. The submucosa showed a tumor containing markedly pleomorphic ovoid to spindle cells arranged in fascicles and bundles. The cells had moderate-to-abundant eosinophilic cytoplasm and raised nucleocytoplasmic ratio. Brisk mitotic activity and areas of necrosis and fibrosis were noted [Figure 2]. A diagnosis of malignant mesenchymal tumor was given. On immunohistochemistry (IHC), tumor cells showed positivity for vimentin, smooth muscle actin (SMA), and desmin and negativity for cytokeratin (CK), rendering the diagnosis of leiomyosarcoma [Figure 3]a and b. Full-body workup did not show any evidence of metastases. The patient's records revealed that he had OSCC 3 years back. At that time, the patient was treated by a radical surgery followed by adjuvant concurrent chemoradiotherapy with a cumulative radiation dose of 66Gy in 33 fractions via external beam RT (EBRT) along with cisplatin. The present case was thus a radiation-induced leiomyosarcoma. As the role of p53 has been implicated in the pathogenesis if RIS, we looked for its expression in the present case. IHC revealed overexpression of p53 with about 30% showing nuclear positivity [Figure 3]c. The patient has now been treated by a margin-negative surgical excision. He has opted out of further radio/chemotherapy and he has been kept under close follow-up.
Figure 1: (a) Clinical picture of the patient with swelling in oral cavity (scar mark of previous surgery for OSCC visible); (b) PET scan revealing hypermetabolic homogenously enhancing soft tissue mass lesion in the oral cavity

Click here to view
Figure 2: (a) Microphotograph showing attenuated mucosa with underlying tumor in submucosa showing interlacing fascicles and bundles of spindle cells (H and E ×100); (b) nuclear pleomorphism and brisk mitoses in tumor (H and E ×400)

Click here to view
Figure 3: (a) Tumor cells showing negativity for CK; (b) cytoplasmic positivity for SMA; (c) nuclear positivity for p53 (IHC ×400)

Click here to view



   Discussion Top


RIS is a well-reported long-term complication of radiotherapy with an incidence rate varying from 0.03% to 0.3%. [4] As radiation carcinogenesis is a stochastic late effect, no "safe" or threshold dose has been reported below which RIS are not seen. Most sarcomas are known to occur after a radiation dose of 55 Gy and above, with a dose ranging from 16 to 112 Gy but there is no consensus on the minimum of cumulative radiation dose or the modality and form of radiation that causes RIS. [1],[5] Nonetheless, a higher prevalence has been observed with EBRT. [2] Combined chemoradiotherapy also increases risk of sarcomas especially with anthracycline-based regimens and alkylating agents. [2] Our patient received cisplatin followed by methotrexate along with EBRT.

Criteria for diagnosing malignancy as radiation induced were firmly established by Cahan et al., in 1948. [6] These criteria comprised (1) an history of RT; (2) origin of radiation-induced malignancy in previously irradiated field; (3) histological evidence of a sarcoma; (4) latency period of at least 5 years between radiation and presentation of radiation induced sarcoma and exclusion of tumor relapse; and (5) the proof, that primary and secondary tumor are different histological entities. Our patient fulfilled four of these criteria. Murray et al., in 1999 included soft tissue sarcomas and a shorter latency period of 5 years to fulfill the criteria for being radiation induced. [7] Although the median latency period in studies reported in the international literature is 10-15 years, technological advances in RT have reduced to this period to months. [1]

The pathogenesis of RIS is still unknown. In regulation of early G1 phase of cell cycle and apoptosis, p53 protein participates. TP53 gene mutations, which are commonly accompanied by immunohistochemical p53 overexpression, appear to play an important role in the causation of postradiation sarcoma as was demonstrated by p53 immunohistochemical positivity in our case. Genetic aberrations in Rb gene have also been implicated. However, recent literature suggests a far more complex pathogenesis warranting more studies. [4],[8]

The most common primary tumors associated with RIS include breast carcinoma, Hodgkin lymphoma, cervical carcinoma, and bone and soft tissue sarcomas. Head and neck region is rarely affected with an incidence rate of 1%. RIS can be of variable histological subtypes. MFH/UPS-NOS is the most common subtype followed by osteosarcoma, angiosarcoma, leiomyosarcoma, fibrosarcoma, and rarely liposarcoma. [1],[4] The rarity of leiomyosarcoma in head and neck region is attributed to scarcity of smooth muscle here. It may be derived from blood vessels, arrector pili, circumvallate papilla, primitive mesenchyme, and myoepithelial cells of salivary glands. [9] Various imaging modalities that have been used for early detection of these sarcomas include x-ray, magnetic resonance imaging (MRI), and CT scan. Lately, FDG-PET is being increasingly used as it shows significant correlation with tumor grade and patient survival. It thus can contribute to individualized patient diagnosis, treatment planning, and response evaluation in such patients. [10] This is the first reported use of 18F-FDG PET/CT in detecting leiomyosarcoma in the oral cavity.

On histopathology, leiomyosarcoma of head and neck region may easily be mistaken for other more common spindle cell lesions in this location, such as tumors of neural sheath, malignant melanoma (spindle cell type), and spindle cell squamous carcinoma. A confirmatory diagnosis can be established by the histomorphology of interlacing fascicles, and bundles of spindle cells with brisk mitotic activity along with IHC for SMA and desmin. [1],[3],[8] There are no specific criteria to distinguish between sporadic and RIS. However, tumor cells and surrounding tissue may show radiation induced changes such as dense fibrosis, necrosis, atrophy, and vascular damage as was seen in our case [Figure 2]. [4]

As surgical excision of RIS of head and neck remains the only definitive treatment option, early diagnosis and a correspondingly better chance of complete surgical resection is essential. Previous radiation and marked fibrotic changes in the irradiated area often limit the effectiveness of any adjuvant chemoradiation. Widely variable latency periods of RIS therefore necessitate lifelong monitoring of the radiated field, even when the patient is free from the primary tumor. [1],[2],[4]

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of intrest.

 
   References Top

1.
Pfeiffer J, Boedeker CC, Ridder GJ, Maier W, Kayser G. Radiation-induced leiomyosarcoma of the oropharynx. Diagn Pathol 2006;1:22.  Back to cited text no. 1
[PUBMED]    
2.
Mavrogenis AF, Pala E, Guerra G, Ruggieri P. Post-radiation sarcomas. Clinical outcome of 52 patients. J Surg Oncol 2012;105:570-6.  Back to cited text no. 2
[PUBMED]    
3.
Weiss SW, Goldblum JR. Enzinger and Weiss's Soft Tissue Tumors. 5 th ed. Philadelphia: CV Mosby; 2008. p. 769-88.  Back to cited text no. 3
    
4.
Thiagarajan A, Iyer NG. Radiation-induced sarcomas of the head and neck. World J Clin Oncol 2014;5:973-81.  Back to cited text no. 4
[PUBMED]    
5.
Khan M, Chandramala R, Sharma R, Vijayalakshmi KR. Radiation-induced spindle cell sarcoma: A rare case report. Indian J Dent Res 2009;20:380-4.  Back to cited text no. 5
[PUBMED]  Medknow Journal  
6.
Cahan WG, Woodard HQ, Higinbotham NL, Steward FW, Coley BL. Sarcoma arising in irradiated bone: Report of eleven cases. 1948. Cancer 1998;82:8-34.  Back to cited text no. 6
    
7.
Murray EM, Werner D, Greeff EA, Taylor DA. Postradiation sarcomas: 20 cases and a literature review. Int J Radiat Oncol Biol Phys 1999;45:951-61.  Back to cited text no. 7
[PUBMED]    
8.
Nakanishi H, Tomita Y, Myoui A, Yoshikawa H, Sakai K, Kato Y, et al. Mutation of the p53 gene in postradiation sarcoma. Lab Invest 1998;78:727-33.  Back to cited text no. 8
    
9.
Amrapala H, Tilakaratne WM. Leiomyosarcoma of the oral cavity: Report of seven cases and review of literature. Oral Oncol Extra 2006;42:14-7.  Back to cited text no. 9
    
10.
Punt SE, Eary JF, O'Sullivan J, Conrad EU. Fluorodeoxyglucose positron emission tomography in leiomyosarcoma: Imaging characteristics. Nucl Med Commun 2009;30:546-9.  Back to cited text no. 10
    


    Figures

  [Figure 1], [Figure 2], [Figure 3]



 

Top
 
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
    Abstract
   Introduction
   Case Report
   Discussion
    References
    Article Figures

 Article Access Statistics
    Viewed2480    
    Printed84    
    Emailed0    
    PDF Downloaded158    
    Comments [Add]    

Recommend this journal